Feline parvovirus recombinant protein and preparation of monoclonal antibody of recombinant protein
A feline parvovirus and monoclonal antibody technology, applied in the field of bioengineering, can solve the problems of slow virus proliferation, high requirements for operators, and high detection costs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0008] Example 1: Selection of Feline Parvovirus Predominant Epitopes
[0009] Taking feline parvovirus capsid protein as the target antigen, using the biological software DNAssist2.0 to analyze the hydrophilicity and antigenicity of the epitope sequence, and selecting the A dominant epitope (SEQ ID No: 1) and the B dominant epitope (SEQ ID No: 2). The results of sequence comparison showed that the selected two dominant antigenic epitopes A and B had high sequence specificity and no obvious homology with other protein sequences.
Embodiment 2
[0010] Example 2: Concatenation of Feline Parvovirus Predominant Epitopes
[0011] In order to enhance the stimulation of the selected antigenic epitopes to the immune system of mice so as to facilitate subsequent experiments, the two dominant antigenic epitope sequences of A and B of the capsid protein of feline parvovirus were connected by flexible fragments (four consecutive glycines). Repeat four times to obtain the amino acid sequence of feline parvovirus recombinant protein, the specific sequence of which is shown in SEQ ID No: 1 in the sequence table.
Embodiment 3
[0012] Example 3: Optimizing the Nucleotide Sequence Encoding Feline Parvovirus Recombinant Protein
[0013] In order to improve the expression of feline parvovirus recombinant protein in Escherichia coli, the amino acid sequence encoding the feline parvovirus recombinant protein was converted into the corresponding nucleotide sequence according to the preferred codons of Escherichia coli under the premise that the amino acid sequence of the recombinant protein remained unchanged , the specific sequence is shown in the sequence table as SEQ ID No: 4, and the nucleotide sequences corresponding to the restriction sites BamHI and EcoRI are added in the upstream and downstream respectively, and synthesized by Hangzhou Xianzhi Biotechnology Co., Ltd. The synthesized target gene was cloned in the pMD19-T vector (Bao Bioengineering Dalian Co., Ltd.).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com